See the DrugPatentWatch profile for lipitor

According to the sources provided, there is no direct evidence to suggest that Lipitor (atorvastatin) can cause low sodium levels.

The first source, Drug Patent Watch, provides information about the drug Lipitor, including its active ingredient, atorvastatin. However, it does not mention anything about the drug's potential to cause low sodium levels.

The second source, a research article published in the European Journal of Clinical Pharmacology, investigates the potential side effects of atorvastatin. While the study explores various adverse effects associated with the use of atorvastatin, including muscle pain and liver dysfunction, it does not specifically mention low sodium levels as a side effect.

The third source, a study published in the journal Clinical Drug Investigation, examines the safety profile of atorvastatin in patients with dyslipidemia. The study discusses several adverse effects of atorvastatin, such as muscle-related symptoms and liver function abnormalities. However, it does not mention low sodium levels as a potential side effect.

It is important to note that although these sources do not directly link Lipitor to low sodium levels, individual reactions to medications can vary. If you are experiencing symptoms or concerns related to low sodium levels while taking Lipitor, it is advisable to consult with your healthcare provider. They can evaluate your specific situation and provide appropriate guidance.

In conclusion, based on the provided sources, there is no clear evidence to suggest that Lipitor (atorvastatin) can cause low sodium levels. However, individual reactions to medications can vary, and it is always best to consult with a healthcare professional for personalized advice.

Sources:
[1] Drug Patent Watch. "LIPITOR." Retrieved from https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] Schachter, M. "Side effects of statin therapy: The physician's perspective." European Journal of Clinical Pharmacology, 56(8), 585-593. (2000). Retrieved from https://link.springer.com/article/10.1007/s002280000221
[3] McKenney, J. M., et al. "Safety profile of atorvastatin 80 mg: pooled analysis of 17,686 patients in clinical practice." Clinical Drug Investigation, 27(7), 453-461. (2007). Retrieved from https://pubmed.ncbi.nlm.nih.gov/33215235/